Company Increases Year-Over-Year Sales, Improves Margins and Reduces Loss From Operations Third Quarter Highlights: Third Quarter 2014 total revenue increased approximately 6.6% to $8.454 million from $7.930 million reported during the third quarter of 2013 Gross profit increased 17.9% to $5.436

BELGRADE, Mont. , Nov. 5, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material and bioactive coatings for medical applications, today announced three senior additions to its Field Sales Organization .

BELGRADE, Mont. , Nov. 4, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material and bioactive coatings for medical applications, today announced the first public presentation of a unique new product line for use in spinal

BELGRADE, Mont., Oct. 29, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material and coatings for medical applications, today announced the release of two unique new products for use in spinal procedures, 3Demin™ Boats and

BELGRADE, Mont. , Oct. 27, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material and coatings for medical applications, has been awarded a grant from the Montana Board of Research and Commercialization Technology (MBRCT)

BELGRADE, Mont. , Oct. 23, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone graft material and coatings for medical applications, today announced that it will release its financial results for the period ended

BELGRADE, Mont. , Oct. 22, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material and coatings for medical applications, presented preclinical results of a robust and efficacious antimicrobial coating for orthopedic

BELGRADE, Mont. , Oct. 20, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material and coatings for medical applications, today announced the launch of a demineralized allograft, 3Demin™ Cortical Fibers.

Third Quarter Total Revenue Expected to be in the Range of $8.4 Million to $8.5 Million, an Increase of Approximately 6 - 7% Over the Same Period Last Year BELGRADE, Mont. , Oct. 16, 2014 (GLOBE NEWSWIRE) -- In a release issued on Tuesday, October 14th 2014 by Bacterin International Holdings, Inc.

Bacterin Attracts Industry Top Sales Management Talent BELGRADE, Mont. , Oct. 16, 2014 (GLOBE NEWSWIRE) -- Bacterin announced today three senior executive additions to its hybrid sales channel. Jeff Whitaker has joined us as Regional Vice President in the Southeast, he brings a track record of